Press Releases

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- Medical device innovation company Soliton, Inc. (Nasdaq: SOLY) today announced that it has engaged Tailfin, an Atlanta based brand and marketing firm, to help develop brand strategy and marketing and sales materials to help power the launch of Soliton's Rapid Acoustic Pulse ("RAP") devi

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will be participating in the 12th Annual LD Micro Main Event Conference in

HOUSTON, Dec. 3, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced today a global, strategic partnership with BAMF Health, an organization that is achieving AI-enabled precision medicine through molecular imaging and theranostics. BAMF Health is also developing a network of advanced cyclotron-equipped r

LONDON, Dec. 3, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce the completion of the first surgeries utilizing its new JOURNEY II Unicompartmental Knee (UK) System. Built on the heritage of the most clinically successful partial knee,1,2 JOURNEY II UK is designed to help patients redisc

ROSEMONT, Ill., Dec. 3, 2019 /PRNewswire/ -- Life Fitness today announced the debut of Life Fitness On Demand™, an innovative and growing library of digital classes available exclusively on the touchscreens of Life Fitness premium cardio products. Life Fitness is the first fitness equipment manufacturer to create digital programming for an entire line of comme

DUBLIN, Dec. 3, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of the first patient in a Phase 2 allergen challenge study of TD-8236, an investigational, lung-selective inhaled pan-Janus kinase (JAK) inhibitor for inflammatory lung diseases. TD-8236 is specifically designed to target ai

CHICAGO, Dec. 3, 2019 /PRNewswire/ -- SullivanCotter, the nation's leading independent consulting firm in the assessment and development of rewards programs and workforce solutions for the health care industry and not-for-profit sector, recently released survey results indicating that physician compensation programs are evolving as organizations address a variety of new

SOUTH AMBOY, N.J., Dec. 3, 2019 /PRNewswire/ -- In response to the nation's opioid crisis and increased demand for services, Recovery Centers of America (RCA) has ope

BOSTON, Dec. 3,  2019 /PRNewswire/ -- ConsumerMedical, a leading clinical advocacy, decision support and expert second opinion company, announced today that David Billi

SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Heron's New Drug Submission (NDS) for HTX-011 for the management of postoperati